Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 6/20 | 0.67 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 1/20 | 0.54 |
| ▸ | CCKAR | P32238 | 1/20 | 0.53 |
| ▸ | CCKBR | P32239 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590552 | 0.93 | GHSR (0.58) | GHSRUTS2R | |
| SCHEMBL31593374 | 0.90 | GHSR (0.64) | GHSR | |
| SCHEMBL29867952 | 0.88 | GHSR (0.62) | GHSRLTA4H | |
| SCHEMBL29564831 | 0.87 | UTS2R (0.64) | GHSRUTS2R | |
| SCHEMBL30052824 | 0.87 | LTA4H (0.67) | GHSRLTA4H | |
| SCHEMBL30051248 | 0.87 | LTA4H (0.67) | GHSRLTA4H | |
| SCHEMBL29577418 | 0.86 | GHSR (0.68) | GHSR | |
| SCHEMBL29405176 | 0.86 | GHSR (0.68) | GHSR | |
| SCHEMBL29577125 | 0.86 | GHSR (0.68) | GHSR | |
| SCHEMBL30169433 | 0.86 | GHSR (0.68) | GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119402044-A | Transmitting wave beam resource pool array face resource management module and method | 中国电子科技集团公司第三十八研究所 | 2025-02-07 | — | — | CN | claimed |
| CN-115469335-B | Ionosphere delay correction method and system based on quasi-four-dimensional model | 武汉大学 | 2024-09-27 | — | — | CN | claimed |
| US-20250371932-A1 | GAMING DEVICE MANAGEMENT ACROSS DIFFERENT GAMING DEVICE CONTROLLERS | IGT (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4568502-A2 | EDIBLE COMPOSITION COMPRISING RECOMBINANT HUMAN SECRETORY PROTEIN | Helaina Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-120117718-A | Repairing agent and repairing method for repairing heavy metal pollution solution by strengthening enzymatic phosphate precipitation under acid rain condition | 西安建筑科技大学 | 2025-06-10 | — | — | CN | disclosed |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | UNIVERSITY OF WASHINGTON | 2025-04-03 | — | — | US | disclosed |
| US-12256197-B2 | Hearing device comprising an input transducer in the ear | OTICON A/S (DK) | 2025-03-18 | — | — | US | disclosed |
| EP-4296373-B1 | NORMALIZATION CONTROLS FOR MANAGING LOW SAMPLE INPUTS IN NEXT GENERATION SEQUENCING | ARC BIO LLC (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-113207299-B | Normalized control for managing low sample input in next generation sequencing | 阿克生物公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-115469335-B | Ionosphere delay correction method and system based on quasi-four-dimensional model | 武汉大学 | 2024-09-27 | — | — | CN | disclosed |
| CN-115327574-B | Satellite-based high-precision ionosphere delay code broadcasting method and system | 武汉大学 | 2024-06-18 | — | — | CN | disclosed |
| CN-112218627-B | Prodrugs and their medical use | 康维尔特制药有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20240064476-A1 | HEARING DEVICE COMPRISING AN INPUT TRANSDUCER IN THE EAR | OTICON A/S (DK) | 2024-02-22 | — | — | US | disclosed |
| WO-2024036227-A2 | EDIBLE COMPOSITION COMPRISING RECOMBINANT HUMAN SECRETORY PROTEIN | HELAINA INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| US-11877851-B2 | Glassy carbon probe and microfabrication method | SAN DIEGO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2024-01-23 | — | — | US | disclosed |
| EP-4296373-A2 | NORMALIZATION CONTROLS FOR MANAGING LOW SAMPLE INPUTS IN NEXT GENERATION SEQUENCING | Arc Bio, LLC (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-3861135-B1 | NORMALIZATION CONTROLS FOR MANAGING LOW SAMPLE INPUTS IN NEXT GENERATION SEQUENCING | ARC BIO LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-116004569-A | Enzyme-induced phosphate precipitation curing agent and application method thereof | 西安建筑科技大学 | 2023-04-25 | — | — | CN | disclosed |
| US-11468410-B2 | Universal payment module and system | VIEWPOST, LLC. (US) | 2022-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | DHFR, CCNH, ODC1 | GHSR 3375/4885UTS2R 780/4885LTA4H 4179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.